Cargando…
Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents
Glioblastoma (GBM) is the most aggressive adult brain tumour with a dismal 2-year survival rate of 26–33%. Maximal safe resection plays a crucial role in improving patient progression-free survival (PFS). Neurosurgeons have the significant challenge of delineating normal tissue from brain tumour to...
Autores principales: | Netufo, Oluwakanyinsolami, Connor, Kate, Shiels, Liam P., Sweeney, Kieron J., Wu, Dan, O’Shea, Donal F., Byrne, Annette T., Miller, Ian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143023/ https://www.ncbi.nlm.nih.gov/pubmed/35631376 http://dx.doi.org/10.3390/ph15050550 |
Ejemplares similares
-
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies
por: Connor, Kate, et al.
Publicado: (2020) -
Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents
por: Miller, Ian S., et al.
Publicado: (2019) -
Continuous Flow Bioconjugations of NIR‐AZA Fluorophores via Strained Alkyne Cycloadditions with Intra‐Chip Fluorogenic Monitoring
por: Fitzgerald, Sheila, et al.
Publicado: (2022) -
Directed self-assembly of fluorescence responsive nanoparticles and their use for real-time surface and cellular imaging
por: Cheung, Shane, et al.
Publicado: (2017) -
Ultrasound Induced Fluorescence of Nanoscale Liposome Contrast Agents
por: Zhang, Qimei, et al.
Publicado: (2016)